Respiratory syncytial virus infection+1
Not recruitingStudying the Effect of Nirsevimab Immunization on Antibody Development After RSV Infection in Healthy Infants
Studying the Effect of Nirsevimab Immunization on Antibody Development After RSV Infection in Healthy Infants
- Disease:Respiratory syncytial virus infectionRespiratory syncytial virus immunisation
- Substances:Nirsevimab
The Netherlands- Participants:0–17 years · Healthy volunteers
- Substances:Nirsevimab
- Sponsor:Rijksinstituut voor Volksgezondheid en Milieu (RIVM)










